The risk of malignancy or progression of existing malignancy in patients with psoriasis treated with biologics: case report and review of the literature-Reference-Cited by-同舟云学术

The risk of malignancy or progression of existing malignancy in patients with psoriasis treated with biologics: case report and review of the literature

Published:2015-12-29 Issue:5 Volume:55 Page:487-493
ISSN:0011-9059
Container-title:International Journal of Dermatology
language:en
Short-container-title:Int J Dermatol

Author:

Patel Shailee¹,Patel Tejas¹,Kerdel Francisco A.¹²

Affiliation:

1. Department of Dermatology & Cutaneous Surgery; University of Miami; Miami FL USA

2. Florida Academic Dermatology Centers; Miami FL USA

Publisher

Wiley

Subject

Dermatology

Reference29 articles.

1. Treatments for psoriasis and the risk of malignancy;Patel;J Am Acad Dermatol,2009

2. Integrated safety analysis: short- and long-term safety profiles of etanercept in patients with psoriasis;Pariser;J Am Acad Dermatol,2012

3. Principles of biological therapy in psoriasis;Caca Biljanovska;Prilozi,2013

4. Long-term safety of biologics in the treatment of moderate-to-severe plaque psoriasis: review of current data;Rustin;Br J Dermatol,2012

5. The risk of malignancy associated with psoriasis;Margolis;Arch Dermatol,2001

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biological Therapy for Psoriasis in Cancer Patients: An 8-Year Retrospective Real-Life Study;Journal of Clinical Medicine;2024-03-27

2. Drug-induced tumoral disease: A global pharmacovigilance database analysis;Therapies;2023-11

3. A retrospective review of the management of patients following a malignancy diagnosis on biologic therapies for the treatment of dermatological disorders;JAAD Case Reports;2023-09

4. Therapeutic monoclonal antibodies with a focus on hereditary angioedema;Allergology International;2023-01

5. Biologic and Small-Molecule Therapies for Moderate-to-Severe Psoriasis: Focus on Psoriasis Comorbidities;BioDrugs;2023-01